Zosano Pharma raises $45M for needle-free drugs
November 15, 2007 | David P. Hamilton
See our story about this Fremont, Calif., specialty pharma in today’s daily briefing at VentureBeat Life Sciences.
Next Story: Roundup: Warner CEO changes online music stance, engineers become scarcer, and more
Previous Story: More about the Google ads that run inside Facebook
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VB Writers
East Coast Editor
Dean TakahashiLead Writer, GamesBeat
National Editor, MobileBeat Lead
Executive Editor
Editor-in-Chief, GamesBeat
Senior Editor
Writer
Writer
Founder & Editor-in-Chief
Writer
Editorial Assistant
Writer
Reviews Editor, GamesBeat
Tom CheredarWriter
Contributor
Julia PlevinContributor
Contributor









